Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ILMN, HRMY, KRTX, EAR, SLGC, and represent 67.03% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 10 stocks: EXAI (+$11M), SGEN (+$6.8M), INCY, BGNE, TRDA, PACB, VIR, REPL, CCXI, ACAD.
- Started 21 new stock positions in TRDA, ACAD, TCRR, TSVT, ARGX, SRPT, KOD, REPL, PACB, AFMD. EXAI, BGNE, SGEN, CERS, INCY, ABCL, DAWN, BMRN, FGEN, ASND, CCXI.
- Reduced shares in these 4 stocks: New Frontier Health Corp ord (-$94M), New Frontier Health Corp *w exp 11/30/202, FLNT, AKRO.
- Sold out of its positions in AKRO, FLNT, New Frontier Health Corp ord, New Frontier Health Corp *w exp 11/30/202.
- Nan Fung Group Holdings was a net seller of stock by $-65M.
- Nan Fung Group Holdings has $211M in assets under management (AUM), dropping by -32.50%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Companies in the Nan Fung Group Holdings portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Illumina (ILMN) | 21.5 | $45M | 130k | 349.40 | ||
| Harmony Biosciences Hldgs In (HRMY) | 17.7 | $37M | 769k | 48.65 | ||
| Karuna Therapeutics Ord (KRTX) | 14.1 | $30M | 235k | 126.79 | ||
| Eargo (EAR) | 7.2 | $15M | 2.9M | 5.29 | ||
| Somalogic Class A Com (SLGC) | 6.5 | $14M | 1.7M | 8.02 | ||
| Exscientia Ads (EXAI) | 5.3 | $11M | NEW | 770k | 14.40 | |
| Seagen (SGEN) | 3.2 | $6.8M | NEW | 47k | 144.05 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 3.2 | $6.7M | 494k | 13.50 | ||
| Xenon Pharmaceuticals (XENE) | 2.9 | $6.0M | 198k | 30.57 | ||
| Vir Biotechnology (VIR) | 2.6 | $5.4M | +31% | 211k | 25.72 | |
| Bolt Biotherapeutics (BOLT) | 1.5 | $3.2M | 1.2M | 2.74 | ||
| Beam Therapeutics (BEAM) | 1.5 | $3.1M | 55k | 57.30 | ||
| Incyte Corporation (INCY) | 1.3 | $2.7M | NEW | 34k | 79.41 | |
| Beigene Sponsored Adr (BGNE) | 1.1 | $2.3M | NEW | 12k | 188.57 | |
Setup an alertNan Fung Group Holdings will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Otonomy (OTIC) | 1.0 | $2.0M | 851k | 2.40 | ||
| Sierra Oncology Com New (SRRA) | 0.8 | $1.7M | 53k | 32.05 | ||
| Entrada Therapeutics (TRDA) | 0.8 | $1.6M | NEW | 174k | 9.39 | |
| Galera Therapeutics (GRTX) | 0.7 | $1.5M | 613k | 2.38 | ||
| Exelixis (EXEL) | 0.7 | $1.5M | 64k | 22.66 | ||
| Pacific Biosciences of California (PACB) | 0.6 | $1.3M | NEW | 145k | 9.10 | |
| Replimune Group (REPL) | 0.6 | $1.3M | NEW | 75k | 16.98 | |
| Invitae (NVTA) | 0.6 | $1.2M | +7% | 156k | 7.97 | |
| EXACT Sciences Corporation (EXAS) | 0.6 | $1.2M | 18k | 69.92 | ||
| Kalvista Pharmaceuticals (KALV) | 0.6 | $1.2M | 79k | 14.74 | ||
| Chemocentryx (CCXI) | 0.4 | $898k | NEW | 36k | 25.06 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $726k | NEW | 30k | 24.21 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $709k | 42k | 16.90 | ||
| 2seventy Bio Common Stock (TSVT) | 0.3 | $687k | NEW | 40k | 17.06 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.3 | $590k | 371k | 1.59 | ||
| Satsuma Pharmaceuticals Ord (STSA) | 0.3 | $543k | 143k | 3.80 | ||
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.2 | $489k | NEW | 4.2k | 117.32 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $471k | NEW | 6.1k | 77.02 | |
| Affimed Therapeutics B V (AFMD) | 0.2 | $355k | NEW | 81k | 4.37 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $350k | NEW | 1.1k | 315.32 | |
| Rubius Therapeutics (RUBY) | 0.1 | $313k | 57k | 5.51 | ||
| Sarepta Therapeutics (SRPT) | 0.1 | $306k | NEW | 3.9k | 78.12 | |
| Reata Pharmaceuticals Cl A (RETA) | 0.1 | $271k | 8.3k | 32.79 | ||
| Fibrogen (FGEN) | 0.1 | $177k | NEW | 15k | 12.00 | |
| Synlogic (SYBX) | 0.1 | $165k | 69k | 2.40 | ||
| Kodiak Sciences (KOD) | 0.1 | $151k | NEW | 20k | 7.70 | |
| Abcellera Biologics (ABCL) | 0.1 | $122k | NEW | 13k | 9.74 | |
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $114k | NEW | 11k | 9.96 | |
| Dyne Therapeutics (DYN) | 0.1 | $112k | 12k | 9.63 | ||
| Cerus Corporation (CERS) | 0.0 | $78k | NEW | 14k | 5.50 | |
| Tcr2 Therapeutics Inc cs (TCRR) | 0.0 | $53k | NEW | 19k | 2.74 | |
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2022 Q1 filed May 13, 2022
- Nan Fung Group Holdings 2021 Q3 filed Nov. 15, 2021
- Nan Fung Group Holdings 2021 Q2 filed Sept. 22, 2021